Stocks To Buy: Macquarie ‘double upgrades’ two hospital stocks for up to 37% upside; details here


Hospital stocks, including Max Healthcare and Apollo Hospitals, are trading with gains of up to 3% on Friday, November 20, after global brokerage Macquarie upgraded both the stocks to ‘Outperform’ from ‘Underperform’, citing improving earnings prospects and more attractive valuations.

The brokerage believes consensus earnings estimate for the hospital sector have bottomed out, while valuations have moderated. It also believes the initial impact of profitability pressures from the ongoing bed expansion cycle is already reflected in stock prices, with newly added capacity ramping up at a healthy pace.

Macquarie upgraded Max Healthcare to ‘Outperform’ from ‘Underperform’ and raised its price target to ₹1,450 from ₹825 per share. The target implies a potential upside of 37% from current levels.

The brokerage favours Max Healthcare because of its more disciplined capital allocation, stronger EBITDA growth outlook and a more favourable trajectory for capacity expansion.

Macquarie expects Max Healthcare to report a compound annual growth rate (CAGR) of 20% in revenue and 22% in EBITDA over FY26–FY29.

Macquarie also upgraded Apollo Hospitals to ‘Outperform’ from ‘Underperform’, while sharply increasing its price target to ₹10,500 from ₹6,230 per share.

Macquarie’s target suggests a further upside of 20% from the Apollo Hospitals stock last closing price on Thursday.

Key risks flagged by Macquarie

The brokerage highlighted the possibility of the Supreme Court extending the price cap beyond oncology drugs, as well as a higher-than-anticipated drag on profitability from newly commissioned hospitals.

For Max Healthcare, the key concern is that a higher share of institutional patients could dilute revenue per patient.

For Apollo Hospitals, rising costs associated with its 24/7 operations could constrain margin expansion in its HealthCo business.

NOTE TO READERS

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Home/Market News/

Stocks To Buy: Macquarie ‘double upgrades’ two hospital stocks for up to 37% upside



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *